1. DSpace-CRIS @ ANLIS
  2. Instituto Nacional de Enfermedades Infecciosas
  3. Publicaciones INEI
Please use this identifier to cite or link to this item: http://sgc.anlis.gob.ar/handle/123456789/2220
DC FieldValueLanguage
dc.contributor.authorKurbatova, E Ves
dc.contributor.authorCavanaugh, J Ses
dc.contributor.authorShah, N Ses
dc.contributor.authorWright, A.es
dc.contributor.authorKim, HeeJines
dc.contributor.authorMetchock, Bes
dc.contributor.authorVan Deun, A.es
dc.contributor.authorBarrera, Lucíaes
dc.contributor.authorBoulahbal, Fes
dc.contributor.authorRichter, Ees
dc.contributor.authorMartín-Casabona, Nes
dc.contributor.authorArias, Fes
dc.contributor.authorZemanova, Ies
dc.contributor.authorDrobniewski, Fes
dc.contributor.authorSantos Silva, Aes
dc.contributor.authorCoulter, Ces
dc.contributor.authorLumb, Res
dc.contributor.authorCegielski, J Pes
dc.date.accessioned2021-01-21T18:29:39Z-
dc.date.available2021-01-21T18:29:39Z-
dc.date.issued2012-
dc.identifier.issn1815-7920-
dc.identifier.urihttp://sgc.anlis.gob.ar/handle/123456789/2220-
dc.descriptionFil: Kurbatova, E V. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.es
dc.descriptionFil: Cavanaugh, J S. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.es
dc.descriptionFil: Shah, N S. Division of General Internal Medicine, Albert Einstein College of Medicine, Bronx, New York; Estados Unidos.es
dc.descriptionFil: Wright, A. World Health Organization, Geneva; Suiza.es
dc.descriptionFil: Kim, HeeJin. Korean Institute of Tuberculosis, Seoul; Korea.es
dc.descriptionFil: Metchock, B. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.es
dc.descriptionFil: Van Deun, A. Institute of Tropical Medicine, Antwerp; Belgica.es
dc.descriptionFil: Barrera, Lucia. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.es
dc.descriptionFil: Boulahbal, F. Institut Pasteur d’Algérie, Alger; Argelia.es
dc.descriptionFil: Richter, E. National Reference Center for Mycobacteria, Borstel; Alemania.es
dc.descriptionFil: Martín-Casabona, N. Hospital Universitaris Vall d’Hebron, Barcelona; España.es
dc.descriptionFil: Arias, F. Institute of Public Health of Chile, Providencia Santiago, Santiago; Chile.es
dc.descriptionFil: Zemanova, I. National Institute of Public Health, Scrobarova; Chequia.es
dc.descriptionFil: Drobniewski, F. Health Protection Agency, London; Reino Unido.es
dc.descriptionFil: Santos Silva, A. National Institute of Health, Porto; Portugal.es
dc.descriptionFil: Coulter, C. Queensland Mycobacterium Reference Laboratory, Brisbane, Queensland; Australia.es
dc.descriptionFil: Lumb, R. Institute of Medical and Veterinary Science, Adelaide, South Australia; Australia.es
dc.descriptionFil: Cegielski, J P. Centers for Disease Control and Prevention, Atlanta, Georgia; Estados Unidos.es
dc.description.abstractBased on data from 14 Supranational Tuberculosis (TB) Reference Laboratories worldwide, the proportion of rifampicin (RMP) resistant isolates that were isoniazid (INH) susceptible by phenotypic drug susceptibility testing varied widely (0.5-11.6%). RMP-resistant isolates that were INH-susceptible had significantly lower rates of resistance to other first- and second-line anti-tuberculosis drugs (except rifabutin) compared to multidrug-resistant isolates. RMP resistance is not always a good proxy for a presumptive diagnosis of multidrug-resistant TB, which has implications for use of molecular assays that identify only RMP resistance-associated DNA mutations.es
dc.formatpdf-
dc.language.isoenes
dc.publisherInternational Union Against Tuberculosis and Lung Diseasees
dc.relation.ispartofThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Diseasees
dc.rightsClosed Access-
dc.sourceInternational Journal of Tuberculosis and Lung Disease 2012 ;16(3):355-7.-
dc.subjectMycobacterium tuberculosises
dc.subjectTuberculosises
dc.subjectResistencia a Medicamentoses
dc.titleRifampicin-resistant Mycobacterium tuberculosis: susceptibility to isoniazid and other anti-tuberculosis drugses
dc.typeArtículoes
dc.identifier.doi10.5588/ijtld.11.0542-
anlis.essnrd1-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.openairetypeArtículo-
item.fulltextWith Fulltext-
item.languageiso639-1en-
Appears in Collections:Publicaciones INEI
Files in This Item:
File Description SizeFormat
10.5588_ijtld.11.0542.pdfArtículo en inglés120.9 kBAdobe PDFView/Open
Show simple item record

Page view(s)

15
checked on May 9, 2024

Download(s)

2
checked on May 9, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.